No Data
No Data
Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Down Nearly 3% for the Week
Dr. Reddy's Laboratories Allocates Equity Shares to Employees
Nomura Upgrades Dr. Reddy's Laboratories to Buy From Neutral, Cuts Price Target to 1,500 Indian Rupees From 6,499 Indian Rupees
Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a New Chief Medical Officer, and Broader Insurance Coverage
Why Dr. Reddy's Laboratories Limited (RDY) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
Dr. Reddy's Launches Toripalimab Immuno-oncology Drug in India